1059 related articles for article (PubMed ID: 19578112)
1. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.
Rabbani MA; Habib HB; Islam M; Ahmad B; Majid S; Saeed W; Shah SM; Ahmad A
Lupus; 2009 Aug; 18(9):848-55. PubMed ID: 19578112
[TBL] [Abstract][Full Text] [Related]
2. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.
Cook RJ; Gladman DD; Pericak D; Urowitz MB
J Rheumatol; 2000 Aug; 27(8):1892-5. PubMed ID: 10955329
[TBL] [Abstract][Full Text] [Related]
3. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
[TBL] [Abstract][Full Text] [Related]
4. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia.
Al Arfaj AS; Khalil N
Lupus; 2009 Apr; 18(5):465-73. PubMed ID: 19318403
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population.
Mok CC; Lee KW; Ho CT; Lau CS; Wong RW
Rheumatology (Oxford); 2000 Apr; 39(4):399-406. PubMed ID: 10817773
[TBL] [Abstract][Full Text] [Related]
6. Long-term prognosis and causes of death in systemic lupus erythematosus.
Doria A; Iaccarino L; Ghirardello A; Zampieri S; Arienti S; Sarzi-Puttini P; Atzeni F; Piccoli A; Todesco S
Am J Med; 2006 Aug; 119(8):700-6. PubMed ID: 16887417
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
[TBL] [Abstract][Full Text] [Related]
8. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
[TBL] [Abstract][Full Text] [Related]
9. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
[TBL] [Abstract][Full Text] [Related]
10. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality.
Abu-Shakra M; Urowitz MB; Gladman DD; Gough J
J Rheumatol; 1995 Jul; 22(7):1265-70. PubMed ID: 7562756
[TBL] [Abstract][Full Text] [Related]
11. Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study.
Cardoso CR; Signorelli FV; Papi JA; Salles GF
Lupus; 2008 Nov; 17(11):1042-8. PubMed ID: 18852231
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus in Thai children: clinicopathologic findings and outcome in 82 patients.
Pattaragarn A; Sumboonnanonda A; Parichatikanond P; Supavekin S; Suntornpoch V; Vongjirad A
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S232-41. PubMed ID: 16856445
[TBL] [Abstract][Full Text] [Related]
13. Young age at onset, renal involvement, and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus.
Marini R; Costallat LT
Rev Rhum Engl Ed; 1999 Jun; 66(6):303-9. PubMed ID: 10418057
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus and lupus syndromes in Senegal. A retrospective study of 30 patients seen over 10 years.
Ka MM; Diallo S; Kane A; Wade B; Diouf B; Diallo A; Moreira-Diop T
Rev Rhum Engl Ed; 1998; 65(7-9):471-6. PubMed ID: 9785393
[TBL] [Abstract][Full Text] [Related]
15. Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment.
Foocharoen C; Nanagara R; Suwannaroj S; Mahakkanukrauh A
Int J Rheum Dis; 2011 Oct; 14(4):353-60. PubMed ID: 22004232
[TBL] [Abstract][Full Text] [Related]
16. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study.
Bellomio V; Spindler A; Lucero E; Berman A; Santana M; Moreno C; Hidalgo RP; Paira S; Graf C; Maldonado Cocco JA; Citera G; Arriola MS; Gómez G; Barreira JC; Messina O; Asnal C; Carrillo D; Gervilla A; García L; Máscolo M; De la Sota M D; Rosso G; Somma LF; Sosa RF; Rillo O; Caracciolo JA; Lancioni G; Gómez A
Lupus; 2000; 9(5):377-81. PubMed ID: 10878732
[TBL] [Abstract][Full Text] [Related]
18. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus.
Ward MM; Pyun E; Studenski S
Arch Intern Med; 1996 Jun; 156(12):1337-44. PubMed ID: 8651844
[TBL] [Abstract][Full Text] [Related]
19. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
Appenzeller S; Pereira DA; Costallat LT
Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
[TBL] [Abstract][Full Text] [Related]
20. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.
Cervera R; Khamashta MA; Font J; Sebastiani GD; Gil A; Lavilla P; Mejía JC; Aydintug AO; Chwalinska-Sadowska H; de Ramón E; Fernández-Nebro A; Galeazzi M; Valen M; Mathieu A; Houssiau F; Caro N; Alba P; Ramos-Casals M; Ingelmo M; Hughes GR;
Medicine (Baltimore); 2003 Sep; 82(5):299-308. PubMed ID: 14530779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
